tiprankstipranks
Fidia Spa (IT:FDA)
:FDA
Italy Market
FDA
Fidia Spa
RESEARCH TOOLSreports

Fidia Spa (FDA) Ratios

6 Followers

Fidia Spa Ratios

IT:FDA's free cash flow for Q2 2025 was €0.70. For the 2025 fiscal year, IT:FDA's free cash flow was decreased by € and operating cash flow was €-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.06 0.82 0.86 4.83 0.84
Quick Ratio
 0.46 0.34 0.44 2.48 0.48
Cash Ratio
 0.10 0.07 0.12 1.13 0.16
Solvency Ratio
 -0.03 -0.32 >-0.01 1.69 -0.04
Operating Cash Flow Ratio
 -0.03 -0.18 -0.19 0.18 0.02
Short-Term Operating Cash Flow Coverage
 -0.36 -4.28 -0.98 0.42 0.11
Net Current Asset Value
€ -4.02M€ -5.82M€ -6.80M€ 16.25M€ -14.79M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.04 0.36 0.26 0.29
Debt-to-Equity Ratio
 0.30 0.34 3.56 1.39 -5.01
Debt-to-Capital Ratio
 0.23 0.26 0.78 0.58 1.25
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.28 0.00 -1.47
Financial Leverage Ratio
 6.26 9.61 10.00 5.39 -17.35
Debt Service Coverage Ratio
 -2.00 -5.65 0.08 3.45 -0.20
Interest Coverage Ratio
 -34.56 -16.55 -2.70 -13.46 -6.85
Debt to Market Cap
 8.16 <0.01 0.01 <0.01 <0.01
Interest Debt Per Share
 0.37 0.04 1.74 1.25 2.37
Net Debt to EBITDA
 0.20 0.09 12.40 0.44 -7.22
Profitability Margins
Gross Profit Margin
71.05%74.17%66.88%5.94%65.14%
EBIT Margin
-14.98%-50.25%-2.15%24.17%-12.28%
EBITDA Margin
-12.01%-43.80%2.33%31.31%-3.73%
Operating Profit Margin
-14.84%-37.58%-5.76%-21.81%-12.87%
Pretax Profit Margin
-4.73%-52.52%-4.28%22.77%-13.67%
Net Profit Margin
-6.25%-53.17%-4.57%24.49%-14.67%
Continuous Operations Profit Margin
-6.94%-54.31%-5.15%23.61%-14.67%
Net Income Per EBT
132.24%101.25%106.69%107.57%107.31%
EBT Per EBIT
31.87%139.75%74.33%-104.37%106.23%
Return on Assets (ROA)
-4.45%-32.85%-4.06%18.57%-8.64%
Return on Equity (ROE)
-30.83%-315.72%-40.62%100.02%149.85%
Return on Capital Employed (ROCE)
-29.81%-148.33%-25.27%-19.10%-38.98%
Return on Invested Capital (ROIC)
-26.28%-120.70%-14.35%-17.89%-23.38%
Return on Tangible Assets
-4.55%-33.41%-4.18%19.17%-8.99%
Earnings Yield
-1619.83%-5.91%-0.21%0.57%-0.36%
Efficiency Ratios
Receivables Turnover
 4.45 3.94 5.21 3.45 2.78
Payables Turnover
 1.14 0.80 1.58 4.16 0.74
Inventory Turnover
 0.53 0.40 0.89 2.26 0.70
Fixed Asset Turnover
 2.63 2.30 3.47 2.61 2.38
Asset Turnover
 0.71 0.62 0.89 0.76 0.59
Working Capital Turnover Ratio
 17.89 -4.34 4.47 4.31 -5.62
Cash Conversion Cycle
 451.09 556.22 250.10 179.60 156.61
Days of Sales Outstanding
 81.98 92.72 70.05 105.86 131.30
Days of Inventory Outstanding
 690.10 919.41 411.61 161.38 518.18
Days of Payables Outstanding
 320.99 455.91 231.56 87.64 492.88
Operating Cycle
 772.07 1.01K 481.66 267.24 649.48
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.13 -0.13 -0.70 0.11 0.11
Free Cash Flow Per Share
 -0.17 -0.13 -0.77 0.07 0.10
CapEx Per Share
 0.05 <0.01 0.07 0.04 0.02
Free Cash Flow to Operating Cash Flow
 1.38 1.02 1.10 0.62 0.85
Dividend Paid and CapEx Coverage Ratio
 -2.65 -40.21 -10.18 2.66 6.79
Capital Expenditure Coverage Ratio
 -2.65 -40.21 -10.18 2.66 6.79
Operating Cash Flow Coverage Ratio
 -0.36 -4.28 -0.42 0.10 0.05
Operating Cash Flow to Sales Ratio
 -0.02 -0.25 -0.17 0.03 0.02
Free Cash Flow Yield
-402.16%-2.83%-0.86%0.05%0.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.06 -16.93 -472.04 174.84 -279.34
Price-to-Sales (P/S) Ratio
 <0.01 9.00 21.57 42.82 40.97
Price-to-Book (P/B) Ratio
 0.02 53.46 191.72 174.87 -418.60
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.25 -35.37 -116.14 2.11K 1.96K
Price-to-Operating Cash Flow Ratio
 -0.16 -36.25 -127.55 1.32K 1.67K
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 -0.40 3.87 -0.77 6.75
Price-to-Fair Value
 0.02 53.46 191.72 174.87 -418.60
Enterprise Value Multiple
 0.13 -20.47 937.38 137.18 -1.11K
Enterprise Value
 -291.31K 156.78M 625.23M 1.05B 983.00M
EV to EBITDA
 0.13 -20.47 937.38 137.18 -1.11K
EV to Sales
 -0.02 8.97 21.86 42.96 41.24
EV to Free Cash Flow
 0.48 -35.22 -117.70 2.11K 1.97K
EV to Operating Cash Flow
 0.66 -36.10 -129.26 1.32K 1.68K
Tangible Book Value Per Share
 1.02 0.07 0.36 3.84 -0.65
Shareholders’ Equity Per Share
 1.17 0.09 0.46 0.86 -0.46
Tax and Other Ratios
Effective Tax Rate
 -0.47 -0.03 -0.20 -0.04 -0.07
Revenue Per Share
 5.23 0.51 4.13 3.51 4.66
Net Income Per Share
 -0.33 -0.27 -0.19 0.86 -0.68
Tax Burden
 1.32 1.01 1.07 1.08 1.07
Interest Burden
 0.32 1.05 1.99 0.94 1.11
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.42 0.16 0.07 0.05 0.09
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.38 0.46 3.70 0.13 -0.17
Currency in EUR